BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 17201804)

  • 1. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
    Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between growth hormone and the thyroid axis in hypopituitary patients.
    Behan LA; Monson JP; Agha A
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):281-8. PubMed ID: 20455887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
    Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
    Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of growth hormone on the plasma levels of T4, free-T4, T3, reverse T3 an TBG in hypopituitary patients.
    Gács G; Bános C
    Acta Endocrinol (Copenh); 1981 Apr; 96(4):475-9. PubMed ID: 6782790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
    Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
    J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.